Literature DB >> 33355476

Prediabetes and What It Means: The Epidemiological Evidence.

Justin B Echouffo-Tcheugui1,2, Elizabeth Selvin2,3.   

Abstract

Prediabetes is an intermediate stage between normal glycemia and diabetes and is highly prevalent, especially in older age groups and obese individuals. Five different definitions of prediabetes are used in current practice, which are based on different cut points of HbA1C, fasting glucose, and 2-h glucose. A major challenge for the field is a lack of guidance on when one definition might be preferred over another. Risks of major complications in persons with prediabetes, including diabetes, cardiovascular disease, kidney disease, and death, also vary depending on the prediabetes definition used. Randomized clinical trials have demonstrated that lifestyle and pharmacologic interventions can be cost-effective, prevent diabetes, and improve cardiovascular risk factors in adults with prediabetes. However, the practical implementation of lifestyle modification or the use of metformin for treating prediabetes is inadequate and complicated by a lack of agreement on how to define the condition. Establishing consensus definitions for prediabetes should be a priority and will help inform expansion of insurance coverage for lifestyle modification and improve current screening and diagnostic practices.

Entities:  

Keywords:  epidemiology; impaired fasting glucose; impaired glucose tolerance; prediabetes

Mesh:

Year:  2021        PMID: 33355476      PMCID: PMC8026645          DOI: 10.1146/annurev-publhealth-090419-102644

Source DB:  PubMed          Journal:  Annu Rev Public Health        ISSN: 0163-7525            Impact factor:   21.981


  111 in total

1.  Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study.

Authors:  Q Gong; E W Gregg; J Wang; Y An; P Zhang; W Yang; H Li; H Li; Y Jiang; Y Shuai; B Zhang; J Zhang; R B Gerzoff; G Roglic; Y Hu; G Li; P H Bennett
Journal:  Diabetologia       Date:  2010-11-03       Impact factor: 10.122

2.  Three of 7 hemoglobin A1c point-of-care instruments do not meet generally accepted analytical performance criteria.

Authors:  Erna Lenters-Westra; Robbert J Slingerland
Journal:  Clin Chem       Date:  2014-05-27       Impact factor: 8.327

3.  Effect of ramipril on the incidence of diabetes.

Authors:  Jackie Bosch; Salim Yusuf; Hertzel C Gerstein; Janice Pogue; Patrick Sheridan; Gilles Dagenais; Rafael Diaz; Alvaro Avezum; Fernando Lanas; Jeffrey Probstfield; George Fodor; Rury R Holman
Journal:  N Engl J Med       Date:  2006-09-15       Impact factor: 91.245

4.  Diabetes and Prediabetes and Risk of Hospitalization: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Andrea L C Schneider; Rita R Kalyani; Sherita Golden; Sally C Stearns; Lisa Wruck; Hsin Chieh Yeh; Josef Coresh; Elizabeth Selvin
Journal:  Diabetes Care       Date:  2016-03-07       Impact factor: 19.112

Review 5.  Evidence and Challenges for Translation and Population Impact of the Diabetes Prevention Program.

Authors:  Ronald T Ackermann; Matthew J O'Brien
Journal:  Curr Diab Rep       Date:  2020-02-20       Impact factor: 4.810

Review 6.  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020.

Authors: 
Journal:  Diabetes Care       Date:  2020-01       Impact factor: 19.112

Review 7.  National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants.

Authors:  Goodarz Danaei; Mariel M Finucane; Yuan Lu; Gitanjali M Singh; Melanie J Cowan; Christopher J Paciorek; John K Lin; Farshad Farzadfar; Young-Ho Khang; Gretchen A Stevens; Mayuree Rao; Mohammed K Ali; Leanne M Riley; Carolyn A Robinson; Majid Ezzati
Journal:  Lancet       Date:  2011-06-24       Impact factor: 79.321

8.  Prevalence, diagnosis, and treatment of impaired fasting glucose and impaired glucose tolerance in nondiabetic U.S. adults.

Authors:  Amrita Karve; Rodney A Hayward
Journal:  Diabetes Care       Date:  2010-08-19       Impact factor: 19.112

9.  Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Bethany Warren; James S Pankow; Kunihiro Matsushita; Naresh M Punjabi; Natalie R Daya; Morgan Grams; Mark Woodward; Elizabeth Selvin
Journal:  Lancet Diabetes Endocrinol       Date:  2016-11-16       Impact factor: 32.069

10.  Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study.

Authors:  Guangwei Li; Ping Zhang; Jinping Wang; Yali An; Qiuhong Gong; Edward W Gregg; Wenying Yang; Bo Zhang; Ying Shuai; Jing Hong; Michael M Engelgau; Hui Li; Gojka Roglic; Yinghua Hu; Peter H Bennett
Journal:  Lancet Diabetes Endocrinol       Date:  2014-04-03       Impact factor: 32.069

View more
  13 in total

Review 1.  Screening for Diabetes and Prediabetes.

Authors:  Daisy Duan; Andre P Kengne; Justin B Echouffo-Tcheugui
Journal:  Endocrinol Metab Clin North Am       Date:  2021-07-12       Impact factor: 4.748

2.  Risk of liver fibrosis in patients with prediabetes and diabetes mellitus.

Authors:  Jongsin Park; Heon-Ju Kwon; Won Sohn; Ju-Yeon Cho; Soo Jin Park; Yoosoo Chang; Seungho Ryu; Byung Ik Kim; Yong Kyun Cho
Journal:  PLoS One       Date:  2022-06-02       Impact factor: 3.752

3.  The Effects of Freshwater Clam (Corbicula fluminea) Extract on Serum Tumor Necrosis Factor-Alpha (TNF-α) in Prediabetic Patients in Taiwan.

Authors:  Tse-Hung Huang; Chiao-Hsu Ke; Chin-Chang Chen; Cheng-Hsun Chuang; Kuang-Wen Liao; Yi-Hsien Shiao; Chen-Si Lin
Journal:  Mar Drugs       Date:  2022-04-10       Impact factor: 6.085

4.  Association of LDL:HDL ratio with prediabetes risk: a longitudinal observational study based on Chinese adults.

Authors:  Maobin Kuang; Nan Peng; Jiajun Qiu; Yanjia Zhong; Yang Zou; Guotai Sheng
Journal:  Lipids Health Dis       Date:  2022-05-15       Impact factor: 4.315

5.  Glycemic Markers and Heart Failure Subtypes: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Justin B Echouffo-Tcheugui; Oluseye Ogunmoroti; Sherita H Golden; Alain G Bertoni; Morgana Mongraw-Chaffin; Ambarish Pandey; Chiadi E Ndumele; Erin D Michos
Journal:  J Card Fail       Date:  2022-01-31       Impact factor: 6.592

6.  Facilitators and barriers for lifestyle change in people with prediabetes: a meta-synthesis of qualitative studies.

Authors:  Gyri Skoglund; Birgitta Blakstad Nilsson; Cecilie Fromholt Olsen; Astrid Bergland; Gunvor Hilde
Journal:  BMC Public Health       Date:  2022-03-21       Impact factor: 3.295

7.  Maintenance of Physical Activity Behavior by Individuals with Prediabetes and Diabetes during the COVID-19 Pandemic after Completing an Exercise Intervention in Brazil.

Authors:  Isabela Coelho Ponciano; Mariana Balbi Seixas; Tiago Peçanha; Adriano Luiz Pereira; Patrícia Fernandes Trevizan; Raquel Rodrigues Britto; Lilian Pinto da Silva
Journal:  Int J Environ Res Public Health       Date:  2022-07-21       Impact factor: 4.614

8.  Acupuncture for Impaired Glucose Tolerance in People With Obesity: A Protocol for a Multicenter Randomized Controlled Trial.

Authors:  Yan Yan; Yuanjie Sun; Xinlu Wang; Lili Zhu; Yu Chen; Zhishun Liu
Journal:  Front Med (Lausanne)       Date:  2022-07-12

9.  Data-driven classification of prediabetes using cardiometabolic biomarkers: Data from National Health and Nutrition Examination Survey 2007-2016.

Authors:  Yan Jiang; Jinying Xia; Caiyan Che; Yongning Wei
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-22       Impact factor: 6.055

10.  Perioperative Cardiometabolic Targets and Coronary Artery Bypass Surgery Mortality in Patients With Diabetes.

Authors:  John P Skendelas; Donna K Phan; Patricia Friedmann; Carlos J Rodriguez; Daniel Stein; Armin Arbab-Zadeh; Stephen J Forest; Leandro Slipczuk
Journal:  J Am Heart Assoc       Date:  2022-04-27       Impact factor: 6.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.